Moderate to Extensive Hepatic Fibrosis (METAVIR F3-4)
1 clinical trials · Condition
◉ Watch Moderate to Extensive Hepatic Fibrosis (METAVIR F3-4)
| Record | Firm | Date |
|---|---|---|
| Phase 1b/2, Open Label, Repeat Dose, Dose Escalation Study of ND-L02-s0201 Injection in Subjects With Moderate to Extensive Fibrosis (METAVIR F3-4) (NCT02227459) | Bristol-Myers Squibb | 2014-10-01 |
Track Moderate to Extensive Hepatic Fibrosis (METAVIR F3-4) automatically
Every clearance here is in the API, with alerts when new ones post.